0.8984

14.44% -0.1516

After Hours: .89 -0.0084 -0.93%

Sol Gel Technologies Ltd (SLGL)

Overview News Price History Option Chain Discussions Forecast

Sol Gel Technologies Ltd stock is traded at $0.8984, with a volume of 562.40K. It is down -14.44% in the last 24 hours and up +109.42% over the past month. Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Previous Close:

$1.05

Open:

$1.02

24h Volume:

562.40K

Relative Volume:

1.19

Market Cap:

$25.03M

Revenue:

$6.56M

Net Income/Loss:

$-14.92M

P/E Ratio:

-1.6637

EPS:

-0.54

Net Cash Flow:

$-33.87M

1W Performance:

-28.70%

1M Performance:

+109.42%

6M Performance:

+9.43%

1Y Performance:

-22.19%

1-Day Range:

$0.8266

$1.10

1-Week Range:

$0.8266

$1.32

52-Week Range:

$0.334

$1.65

Sol Gel Technologies Ltd Stock (SLGL) Company Profile

Name

Sol Gel Technologies Ltd

Sector

Healthcare (1176)

Industry

Biotechnology (685)

Phone

Address

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

SLGL's Discussions on Twitter

Compare SLGL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLGL Sol Gel Technologies Ltd	0.8984	25.03M	6.56M	-14.92M	-33.87M	-0.54
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-19-24	Downgrade	Raymond James	Strong Buy → Outperform
Oct-21-22	Resumed	Jefferies	Hold
Dec-31-19	Reiterated	H.C. Wainwright	Buy
Dec-31-19	Reiterated	JMP Securities	Mkt Outperform

Sol Gel Technologies Ltd Stock (SLGL) Latest News

Jan 14, 2025

Rosacea Pipeline Analysis, Clinical Trials, EMA, PDMA, FDA - openPR

Jan 14, 2025

Jan 13, 2025

Actinic Keratosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Jan 13, 2025

Acne Vulgaris Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA by DelveInsight | Dermata Therapeutics, AstraZeneca, Novartis, UCB Pharma, Incyte Inc., Galderma - The Globe and Mail

Jan 13, 2025

Jan 09, 2025

DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times

Jan 09, 2025

Jan 08, 2025

Acne Vulgaris Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News

Jan 08, 2025

There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump - Simply Wall St

Dec 24, 2024

Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 24, 2024

Dec 23, 2024

United States shares higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com India

Dec 23, 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com

Dec 23, 2024

SLGL Stock Touches 52-Week High at $1.65 Amid Market Fluctuations - Investing.com

Dec 23, 2024

The Next-Generation Solar Cell Market Set to Reach $12.91 Billion by 2031. - openPR

Dec 23, 2024

Dec 19, 2024

Rosacea Treatment Market Growth in Future Scope 2024-2031 | - openPR

Dec 19, 2024

Dec 10, 2024

Solar Lighting System Market Trends and Future Opportunities 2024-2032 - openPR

Dec 10, 2024

Nov 25, 2024

Acne Vulgaris Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR

Nov 25, 2024

Nov 22, 2024

Global Solar Street Lighting Market to Reach USD 12.38 Billion by 2029, Growing at a CAGR of 14.5% - openPR

Nov 22, 2024

Nov 21, 2024

Revolutionary Solar Lighting Innovations for 2024 - openPR

Nov 21, 2024

Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 21, 2024

Sol-Gel receives Nasdaq compliance extension By Investing.com - Investing.com Nigeria

Nov 21, 2024

Nov 20, 2024

Sol-Gel Technologies Reports Strong Q3 2024 Results - TipRanks

Nov 20, 2024

SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Nov 20, 2024

Sol-Gel receives Nasdaq compliance extension - Investing.com India

Nov 20, 2024

SEALSQ updates on minimum bid price non-compliance - MSN

Nov 20, 2024

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement - The Manila Times

Nov 20, 2024

Microlise Group Reassures Investors After Cyber Incident - MSN

Nov 20, 2024

Sol-Gel Receives Final Nasdaq Warning, Faces Delisting Risk After Market Downgrade - StockTitan

Nov 20, 2024

Nov 19, 2024

Solar Lighting System Market Current Status and Future Prospects till 2031 - openPR

Nov 19, 2024

Smudge-Free Innovations: 2024 Global Market Insights on Anti-Fingerprint Coatings In The Latest Report - WhaTech

Nov 19, 2024

GlobalData Executes Share Buyback Program - MSN

Nov 19, 2024

Nov 16, 2024

Sol Gel Tech earnings beat by $0.04, revenue topped estimates - Investing.com South Africa

Nov 16, 2024

Nov 15, 2024